Hughes G D, Puoane T R, Clark B L, Wondwossen T L, Johnson Q, Folk W
South African Herbal Science and Medicine Institute (SAHSMI), University of the Western Cape, Belleville, South Africa.
Afr J Tradit Complement Altern Med. 2012 Jul 1;9(4):470-84. doi: 10.4314/ajtcam.v9i4.4. eCollection 2012.
Previous studies have reported that majority of antiretroviral (ARV) treatment-naïve patients use traditional medicine (TM). Given that TM use is ubiquitous in South Africa especially for chronic conditions, there is a potential for ARV non-adherence and serious drug interactions among patients with HIV/AIDs who use TM. The motivating factors for TM use in HIV/AIDS patients on ARV and prophylaxis treatment have not been well defined in South Africa. This study aimed to investigate the prevalence, facilitators, predictors, and types of TM used among persons living with HIV/AIDS on antiretroviral treatment. The study was a cross-sectional survey which involved 100 participants enrolled at ARV clinics in two South African provinces. Univariate and bivariate analyses were performed to assess the relationships between variables and potential predictors of TM. Sixteen percent of participants on ARV reported TM use. Seventy-nine percent used TM prior to a diagnosis of HIV. Participants were more likely to use TM if they were from a rural province, female, older, unmarried, employed, had limited education, or were HIV-positive for less than five years. TM users reported utilizing herbal or medicinal mixtures that were claimed to heal all conditions. This study provides insights into the treatment modalities selected by patients with HIV/AIDS in South Africa who are receiving ARV. This study revealed that less than 20% of participants co-used TM and ARV. However, close to 80% of participants utilize TM before contracting HIV, which is in keeping with approximate estimates by the WHO.
以往研究报告称,大多数未接受过抗逆转录病毒(ARV)治疗的患者使用传统药物(TM)。鉴于在南非,尤其是对于慢性病患者,使用传统药物的现象很普遍,因此,在使用传统药物的艾滋病毒/艾滋病患者中,存在抗逆转录病毒治疗依从性差和严重药物相互作用的可能性。在南非,艾滋病毒/艾滋病患者在接受抗逆转录病毒治疗和预防治疗时使用传统药物的驱动因素尚未得到明确界定。本研究旨在调查接受抗逆转录病毒治疗的艾滋病毒/艾滋病患者中传统药物的使用 prevalence、促进因素、预测因素及类型。该研究为横断面调查,涉及在南非两个省份的抗逆转录病毒诊所登记的100名参与者。进行单变量和双变量分析以评估变量与传统药物潜在预测因素之间的关系。16% 的接受抗逆转录病毒治疗的参与者报告使用传统药物。79% 的参与者在被诊断出感染艾滋病毒之前就使用传统药物。如果参与者来自农村省份、女性、年龄较大、未婚、就业、教育程度有限或感染艾滋病毒不到五年,则更有可能使用传统药物。使用传统药物的参与者报告使用了据称能治愈所有疾病的草药或药用混合物。本研究为南非接受抗逆转录病毒治疗的艾滋病毒/艾滋病患者选择的治疗方式提供了见解。该研究表明,不到20% 的参与者同时使用传统药物和抗逆转录病毒药物。然而,近80% 的参与者在感染艾滋病毒之前就使用传统药物,这与世界卫生组织的大致估计一致。